Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TSC-101 by TScan Therapeutics for Myelodysplastic Syndrome: Likelihood of Approval
TSC-101 is under clinical development by TScan Therapeutics and currently in Phase I for Myelodysplastic Syndrome. According to GlobalData, Phase...
TSC-101 by TScan Therapeutics for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
TSC-101 is under clinical development by TScan Therapeutics and currently in Phase I for Acute Myelocytic Leukemia (AML, Acute Myeloblastic...
TSC-101 by TScan Therapeutics for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia): Likelihood of Approval
TSC-101 is under clinical development by TScan Therapeutics and currently in Phase I for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic...